相关实验视频

Updated: Jan 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

儿童在社区获得的肺炎

David Basile¹, Stephen Sandelich²

¹Department of Emergency Medicine, Penn State College of Medicine, Hershey, PA, USA.

Emergency medicine clinics of North America

|October 17, 2025

概括

儿童的社区性肺炎 (CAP) 通常是病毒性,但也可能是细菌性. 本综述更新了儿科CAP的诊断,管理和预防策略,强调了这种常见的呼吸道感染的最新方法.

科学领域:

儿科肺病学儿科肺病学
传染性疾病传染性疾病
呼吸系统医学呼吸系统医学

背景情况:

社区获得性肺炎 (CAP) 是一个常见的儿科呼吸道感染.
病毒性病因是最常见的,但细菌病原体如肺炎 estreptococcus 和 Mycoplasma pneumoniae 是重要的贡献者.
目前的诊断和治疗指南需要更新,因为不断变化的趋势.

研究的目的:

提供关于儿科CAP的诊断,管理和预防的最新审查.
突出当前的流行病学趋势及其对临床实践的影响.
为管理儿科CAP的医疗保健专业人员提供一个全面的资源.

主要方法:

关于儿科CAP的最新研究的文献综述.
对诊断方法的分析,包括临床发现和成像.
评估当前的治疗策略,包括抗生素和支持性护理.
审查疫苗接种影响和未来的研究需求.

主要成果:

病毒病因在儿科CAP中占主导地位.
临床评估是诊断的主要;成像仅用于严重病例.
治疗因病因而有所不同:阿莫西西林用于细菌性CAP,宏类用于非典型肺炎.
支持性护理,包括氧气,对于严重的表现至关重要.
疫苗接种已经降低了死亡率,但需要进行持续的研究.

结论:

对儿科CAP诊断和管理采取更新的,基于证据的方法至关重要.
为了应对新的流行病学趋势,需要继续进行研究.
有效的预防策略,包括疫苗接种,仍然至关重要.

关键词:

儿童呼吸道感染儿童呼吸道感染在社区获得的肺炎.复杂性复杂性复杂性菌质体菌质体是什么?儿科急诊医学儿科急诊医学儿科肺炎儿科肺炎是指儿童的肺炎.肺炎的诊断是肺炎的诊断.肺炎治疗方法肺炎治疗方法

更多相关视频

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

相关概念视频

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...